Who invested in Bioprognos?
Bioprognos's investors include Capital Cell.

Funding summaryUpdated 26 Oct 2026
$417Kraised across 1 round since 2016, from 1 source
Bioprognos's investors include Capital Cell.
Bioprognos has raised $417K across 1 round since 2016.
Bioprognos's most recent round was a Seed of $417K in Aug 2016.
Its most recent round, $417K in Aug 2016, is also its largest on record.
Bioprognos's first round on record, in Aug 2016, was backed by Capital Cell.
Bioprognos's latest named round is a Seed, in Aug 2016.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.